Here's the replay and chartbook from first Breakout Multiplier Mastermind class, in which I discuss the basic tenants of the Breakout Multiplier strategy and how to get the most out of it.
Baker Bros Advisors, renowned for their biotech expertise, increased their stake in Bicycle Therapeutics $BCYC from 19.76% to 22.90%, as disclosed in a 13D filing.
From time to time, I like to play devil's advocate as part of an exercise to identify potential wrenches and better understand the market environment we might be heading into.
